Search

Your search keyword '"Drachenberg, C."' showing total 293 results
Start Over Author "Drachenberg, C." Language english
293 results on '"Drachenberg, C."'

1. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

Author

Loupy, A., Haas, M., Solez, K., Racusen, L., Glotz, D., Seron, D., Nankivell, B. J., Colvin, R. B., Afrouzian, M., Akalin, E., Alachkar, N., Bagnasco, S., Becker, J. U., Cornell, L., Drachenberg, C., Dragun, D., de Kort, H., Gibson, I. W., Kraus, E. S., Lefaucheur, C., Legendre, C., Liapis, H., Muthukumar, T., Nickeleit, V., Orandi, B., Park, W., Rabant, M., Randhawa, P., Reed, E. F., Roufosse, C., Seshan, S. V., Sis, B., Singh, H. K., Schinstock, C., Tambur, A., Zeevi, A., and Mengel, M.

Published
2017
Full Text
View/download PDF

8. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

Author

Solez, K., Colvin, R.B., Racusen, L.C., Haas, M., Sis, B., Mengel, M., Halloran, P.F., Baldwin, W., Banfi, G., Collins, A.B., Cosio, F., David, D.S.R., Drachenberg, C., Einecke, G., Fogo, A.B., Gibson, I.W., Glotz, D., Iskandar, S.S., Kraus, E., Lerut, E., Mannon, R.B., Mihatsch, M., Nankivell, B.J., Nickeleit, V., Papadimitriou, J.C., Randhawa, P., Regele, H., Renaudin, K., Roberts, I., Seron, D., Smith, R.N., and Valente, M.

Published
2008
Full Text
View/download PDF

14. Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

Author

Haas, M., Sis, B., Racusen, L. C., Solez, K., Glotz, D., Colvin, R. B., Castro, M. C. R., David, D. S. R., David-Neto, E., Bagnasco, S. M., Cendales, L. C., Cornell, L. D., Demetris, A. J., Drachenberg, C. B., Farver, C. F., Farris, A. B., III, Gibson, I. W., Kraus, E., Liapis, H., Loupy, A., Nickeleit, V., Randhawa, P., Rodriguez, E. R., Rush, D., Smith, R. N., Tan, C. D., Wallace, W. D., and Mengel, M.

Published
2014
Full Text
View/download PDF

24. Guidelines for the Diagnosis of Antibody-Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema

Author

Drachenberg, C. B., Torrealba, J. R., Nankivell, B. J., Rangel, E. B., Bajema, I. M., Kim, D. U., Arend, L., Bracamonte, E. R., Bromberg, J. S., Bruijn, J. A., Cantarovich, D., Chapman, J. R., Farris, A. B., Gaber, L., Goldberg, J. C., Haririan, A., Honsová, E., Iskandar, S. S., Klassen, D. K., Kraus, E., Lower, F., Odorico, J., Olson, J. L., Mittalhenkle, A., Munivenkatappa, R., Paraskevas, S., Papadimitriou, J. C., Randhawa, P., Reinholt, F. P., Renaudin, K., Revelo, P., Ruiz, P., Samaniego, M. D., Shapiro, R., Stratta, R. J., Sutherland, D. E. R., Troxell, M. L., Voska, L., Seshan, S. V., Racusen, L. C., and Bartlett, S. T.

Published
2011
Full Text
View/download PDF

27. Banff ʼ09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

Author

Sis, B., Mengel, M., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Baldwin, W. M., III, Bracamonte, E. R., Broecker, V., Cosio, F., Demetris, A. J., Drachenberg, C., Einecke, G., Gloor, J., Glotz, D., Kraus, E., Legendre, C., Liapis, H., Mannon, R. B., Nankivell, B. J., Nickeleit, V., Papadimitriou, J. C., Randhawa, P., Regele, H., Renaudin, K., Rodriguez, E. R., Seron, D., Seshan, S., Suthanthiran, M., Wasowska, B. A., Zachary, A., and Zeevi, A.

Published
2010
Full Text
View/download PDF

32. Banff Schema for Grading Pancreas Allograft Rejection: Working Proposal by a Multi-Disciplinary International Consensus Panel

Author

Drachenberg, C. B., Odorico, J., Demetris, A. J., Arend, L., Bajema, I. M., Bruijn, J. A., Cantarovich, D., Cathro, H. P., Chapman, J., Dimosthenous, K., Fyfe-Kirschner, B., Gaber, L., Gaber, O., Goldberg, J., Honsová, E., Iskandar, S. S., Klassen, D. K., Nankivell, B., Papadimitriou, J. C., Racusen, L. C., Randhawa, P., Reinholt, F. P., Renaudin, K., Revelo, P. P., Ruiz, P., Torrealba, J. R., Vazquez-Martul, E., Voska, L., Stratta, R., Bartlett, S. T., and Sutherland, D. E. R.

Published
2008

33. Banff ʼ05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’)

Author

Solez, K., Colvin, R. B., Racusen, L. C., Sis, B., Halloran, P. F., Birk, P. E., Campbell, P. M., Cascalho, M., Collins, A. B., Demetris, A. J., Drachenberg, C. B., Gibson, I. W., Grimm, P. C., Haas, M., Lerut, E., Liapis, H., Mannon, R. B., Marcus, P. B., Mengel, M., Mihatsch, M. J., Nankivell, B. J., Nickeleit, V., Papadimitriou, J. C., Platt, J. L., Randhawa, P., Roberts, I., Salinas-Madriga, L., Salomon, D. R., Seron, D., Sheaff, M., and Weening, J. J.

Published
2007

40. BANFF 07 CLASSIFICATION OF RENAL ALLOGRAFT PATHOLOGY: UPDATES AND FUTUREDIRECTIONS

Author

Solez, K, Colvin, Rb, Racusen, Lc, Haas, M, Sis, B, Mengel, M, Halloran, Pf, Baldwin, W, Banfi, G, Collins, Ab, Cosio, F, David, Ds, Drachenberg, C, Einecke, G, Fogo, Ab, Gibson, Iw, Glotz, D, Iskandar, Ss, Kraus, E, Lerut, E, Mannon, Rb, Mihatsch, M, Nankivell, Bj, Nickeleit, V, Papadimitriou, Jc, Randhawa, P, Regele, H, Renaudin, K, Roberts, I, Seron, D, Smith, Rn, Valente, Marialuisa, Apr, and EPUB FEB, .

Subjects
renal transplant, Pathology
Published
2008

41. Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

Author

Sis, B., Mengel, M., Haas, M., Colvin, R.B., Halloran, P.F., Racusen, L.C., Solez, K., Baldwin, W.M., III, Bracamonte, E.R., Broecker, V., Cosio, F., Demetris, A.J., Drachenberg, C., Einecke, G., Gloor, J., Glotz, D., Kraus, E., Legendre, C., Liapis, H., Mannon, R.B., Nankivell, B.J., Nickeleit, V., Papadimitriou, J.C., Randhawa, P., Regele, H., Renaudin, K., Rodriguez, E.R., Seron, D., Seshan, S., Suthanthiran, M., Wasowska, B.A., Zachary, A., and Zeevi, A.

Published
2010
Full Text
View/download PDF

44. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

Author

Loupy, A., Haas, M., Solez, K., Racusen, L., Glotz, D., Seron, D., Nankivell, B. J., Colvin, R. B., Afrouzian, M., Akalin, E., Alachkar, N., Bagnasco, S., Becker, J. U., Cornell, L., Drachenberg, C., Dragun, D., de Kort, H., Gibson, I. W., Kraus, E. S., Lefaucheur, C., Legendre, C., Liapis, H., Muthukumar, T., Nickeleit, V., Orandi, B., Park, W., Rabant, M., Randhawa, P., Reed, E. F., Roufosse, C., Seshan, S. V., Sis, B., Singh, H. K., Schinstock, C., Tambur, A., Zeevi, A., and Mengel, M.

Subjects
Meeting Report, clinical research/practice, translational research/science, kidney transplantation/nephrology, pathology/histopathology, organ transplantation in general, rejection, rejection: antibody‐mediated (, rejection: subclinical, rejection: T cell mediated (
Abstract

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d‐negative antibody‐mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor‐specific antibody tests (anti‐HLA and non‐HLA) with transplant histopathology, and questions of molecular transplant diagnostics. The use of transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to supplement the diagnosis and classification of rejection requires further consensus agreement and validation in biopsies. Newly introduced concepts include the i‐IFTA score, comprising inflammation within areas of fibrosis and atrophy and acceptance of transplant arteriolopathy within the descriptions of chronic active T cell–mediated rejection (TCMR) or chronic ABMR. The pattern of mixed TCMR and ABMR was increasingly recognized. This report also includes improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification. The goal of the Banff process is ongoing integration of advances in histologic, serologic, and molecular diagnostic techniques to produce a consensus‐based reporting system that offers precise composite scores, accurate routine diagnostics, and applicability to next‐generation clinical trials.

Published
2016
Full Text
View/download PDF

45. Cholesterol embolization syndrome induced by thrombolytic therapy [corrected] [published erratum appears in AM J CARDIOVASC DRUGS 2008;8(6):427].

Author

Hitti WA, Wali RK, Weiman EJ, Drachenberg C, and Briglia A

Abstract

Cholesterol embolization syndrome (CES) induced by thrombolytic therapy is a rare syndrome with a high incidence of morbidity and mortality. The variability in clinical presentations may cause a delay in diagnosis of CES. This article presents a comprehensive review of the English literature from January 1980 to December 2007 identifying all published case reports of CES induced by thrombolytic therapy. Multiple electronic databases were searched and relevant reference lists were hand searched to identify all case reports.Thirty cases of thrombolytic-induced CES were identified. Indications for thrombolysis were acute myocardial infarction (28 patients) and deep venous thrombosis (two patients). Skin and renal involvement were the most common presentations. Skin manifestations included livedo reticularis, rash, and skin mottling. Other clinical symptoms included cyanotic toes, gastrointestinal bleeding, or perforation, myalgias, retinal emboli, and CNS involvement.Morbidity and mortality were high. Outcomes included chronic hemodialysis in eight patients, four patients underwent amputations, seven patients developed or had progression of their chronic kidney disease, and seven deaths occurred.CES presents as multiorgan dysfunction and should be considered in the differential diagnosis of the symptom complex that may develop after thrombolytic therapy. Diagnosis of CES can be difficult as a result of the variable clinical presentations. A thorough clinical history and physical examination are essential first steps in establishing a diagnosis. Confirmatory diagnosis requires biopsy of the target organs. Measures to reduce the likelihood of recurrence should be taken and include avoidance of anticoagulation therapy and vascular procedures. Unfortunately, therapy remains supportive and the outcome is invariably poor. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

46. Transplantation.

Author

Ramos, Emilio, Drachenberg, C. B., Papadimitriou, J. C., Ishani, A., Erturk, S., Hertz, M. I., Cattaneo, D., Perico, Norberto, Gaspari, F., Rentenaar, R. J., Van Diepen, F. N. J., Meijer, R. T., McDonald, Stephen, Russ, G. R., Weber, M., Dindo, D., Demartines, N., Nicholson, M. L., and Waller, J. R.

Subjects
*TRANSPLANTATION of organs, tissues, etc., *KIDNEYS, *LUNGS, *EXTRACELLULAR matrix, *HOMOGRAFTS
Abstract

Presents several studies on transplantation. Predictors of renal function following lung or heart-lung transplantation; Association between cyclosporine-sparing agent use and outcomes in kidney transplant recipients; Relationship between intragraft expression of genes controlling the accumulation of extracellular matrix and development of chronic renal allograft nephropathy in human renal transplants; Influence of immunosuppressive treatment protocols on the immune system.

Published
2003

50. Fibrous mastocytoma in a patient with generalized cutaneous mastocytosis.

Author

Wood, C., Sina, B., Webster, C. G., Kurgansky, D., Drachenberg, C. B., and Reedy, E. A.

Subjects
MAST cell disease, CONNECTIVE tissue diseases, PIGMENTATION disorders, IMMUNOLOGIC diseases, FIBROBLASTS, CONNECTIVE tissue cells
Abstract

A 57-year-old woman with cutaneous mastocytosis of 23 years duration developed a hyperpigmented abdominal plaque composed of confluent indurated papules that enlarged for a period of 1 year to 12 × 8 cm. Biopsy showed dermal infiltration by closely packed spindle-shaped mast cells, fibroblasts, collagen, and scattered lymphocytes, predominately T-suppressor cells. Electron microscopy showed close contact between mast cells, fibroblasts, and lymphocytes. Piecemeal mast cell degranulation and extrusion of mast cell granules was seen, with rare mast cell granules in fibroblasts, and collagen fibres in peripheral and perinuclear endoplasmic reticulum of mast cells. The term Fibrous mastocytoma is suggested for this tumor-like dermal fibrosis, possibly induced by lymphokines. [ABSTRACT FROM AUTHOR]

Published
1992
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results